Estrogen enhances progesterone-induced stimulation of proliferation and differentiation of osteoprogenitors in cell populations derived from adult human bone

雌激素增强黄体酮诱导的成人骨细胞群中骨祖细胞增殖和分化的刺激

基本信息

  • 批准号:
    17591576
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

Previous experiments have demonstrated that bone cell populations derived from explants of lumbar vertebral bone of adult female rats contain osteoprogenitors that require dexamethasone (Dex) or progesterone (Prog) to proliferate and differentiate into fully differentiated bone-forming osteoblasts. This study was conducted to determine whether these findings found in rat are also observed in human using human cells. First, the present study was undertaken to determine the frequency and/or number of Dex and Prog-responsive osteoprogenitors in cell populations. Frequencies and numbers of progenitor types were determined for up to six subcultures using continuous subculturing, limiting dilution analysis, and colony assays. In Dex-containing medium, subculturing resulted in a 10% increase in the total number of Dex-responsive osteoprogenitors in second subculture cells over first subculture cell. From the third subculture onward, the frequency of osteoprogenitors decreased in a linear mann … More er and none were observed after five subcultures. Similar results were obtained in Prog-containing medium. Limiting dilution analysis in the presence of Dex indicated that 1.81% of cells represented a colony forming unit-fibroblast and 0.25% represented an osteoprogenitor in first subculture cells. In the presence of Prog indicated that 1.75% of cells represented a colony forming unit-fibroblast and 0.09% represented an osteoprogenitor in first subculture cells. Second, we show that the Prog-dependent population can be detected in female bone after sexual maturation, and can be induced by culturing the osteoprogenitors in media containing 17 β-estradiol (10-9-10-8m). This suggested that the survival of the Prog-dependent osteoprogenitors and/or their ability to proliferate is dependent on the presence of estrogen. The results presented here are compatible with the view that in the female skeleton one of the mechanisms maintaining bone mass is related to effects of both estrogen and Prog on a class of osteoprogenitors responsive to Prog. These findings may provide new insight into the significance of a specific class of Prog-dependent osteoprogenitors and of their regulation by estrogen in the human skeleton. Less
先前的实验已经证明,来自成年雌性大鼠腰椎骨外植体的骨细胞群含有骨祖细胞,其需要地塞米松(Dex)或孕酮(Prog)增殖并分化成完全分化的成骨细胞。本研究旨在确定在大鼠中发现的这些发现是否也在使用人类细胞的人类中观察到。首先,进行本研究以确定细胞群中Dex和Prog-responsive骨祖细胞的频率和/或数量。使用连续传代培养、有限稀释分析和集落测定法,确定了多达6次传代培养的祖细胞类型的频率和数量。在含Dex的培养基中,继代培养导致第二次继代培养细胞中Dex反应性骨祖细胞的总数比第一次继代培养细胞增加10%。从第三次传代开始,骨祖细胞的频率呈线性下降, ...更多信息 在5次传代培养后未观察到ER。在含Prog-containing培养基中获得了类似的结果。在Dex存在下的有限稀释分析表明,在第一次传代细胞中,1.81%的细胞代表集落形成单位-成纤维细胞,0.25%代表骨祖细胞。在存在Prog的情况下,表明在第一次传代培养细胞中,1.75%的细胞代表集落形成单位-成纤维细胞,0.09%代表骨祖细胞。第二,我们发现在性成熟后的女性骨中可以检测到Prog-dependent群体,并且可以通过在含有17 β-雌二醇(10-9-10- 8 m)的培养基中培养骨祖细胞来诱导。这表明Prog-dependent骨祖细胞的存活和/或其增殖能力依赖于雌激素的存在。这里提出的结果是兼容的观点,在女性骨骼的机制之一,保持骨量有关的影响,雌激素和Prog对一类骨祖细胞响应Prog。这些发现可能提供了新的见解的意义,一类特定的Prog-dependent骨祖细胞和雌激素在人类骨骼中的调节。少

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Progestins with No Glucocorticoid Activity May Be a Better Choice for Hormone Replacement Therapy to Achieve More Beneficial Effects on Bone Metabolism
无糖皮质激素活性的孕激素可能是激素替代疗法的更好选择,以对骨代谢产生更有益的效果
Juvenile rheumatoid arthritis manifesting in only limping due to flexion contraction of the knee
幼年型类风湿性关节炎仅表现为因膝关节屈曲收缩而跛行
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishida Y;Yara T;Imamura R;Taguchi T.;Takatomo Mine
  • 通讯作者:
    Takatomo Mine
Age-related Efficacy of Alendronate, Risedronate, and Etidronate in Posttnenopausal Women with Osteoporosis
阿仑膦酸钠、利塞膦酸钠和依替膦酸钠对绝经后骨质疏松症妇女的年龄相关疗效
Locked knee caused by intraarticular ganglion. 2006
关节内神经节引起的锁膝。
Factors Affecting Ambulatory Status and Survival of Osteoporosis Patients 90 Years and Older with Hip Fractures
影响 90 岁及以上髋部骨折骨质疏松症患者行走状态和生存的因素
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishida Y;Taguchi T.;Yoichiro Ishida;Yoichiro Ishida;Yoichiro Ishida
  • 通讯作者:
    Yoichiro Ishida
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIDA Yoichiro其他文献

ISHIDA Yoichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIDA Yoichiro', 18)}}的其他基金

Progesterone stimulates osteoprogenitor proliferation and differentiation in osteoblast-like cell populations derived from adult female rat vertebrae
黄体酮刺激源自成年雌性大鼠椎骨的成骨细胞样细胞群中的骨祖细胞增殖和分化
  • 批准号:
    15591579
  • 财政年份:
    2003
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer
项目3:绝经前妇女肥胖和子宫内膜增生/癌症的一级预防和子宫保留
  • 批准号:
    10711638
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
プロゲスチンが卵子に及ぼす作用機序の解明とPPOS法の最適な治療プロトコルの確立
阐明孕激素对卵子的作用机制并建立PPOS法最佳治疗方案
  • 批准号:
    23K08867
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Progesterone promotes mammary gland tumorigenesis through immunosuppressive effects on dendritic cells
黄体酮通过对树突状细胞的免疫抑制作用促进乳腺肿瘤发生
  • 批准号:
    10626769
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Targeting the Progesterone Receptor as a Novel Means to Increase Efficacy of Immune Checkpoint Inhibitors in Hormone Receptor Positive Breast Cancer
靶向黄体酮受体作为提高激素受体阳性乳腺癌免疫检查点抑制剂疗效的新方法
  • 批准号:
    10512899
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Progesterone promotes mammary gland tumorigenesis through immunosuppressive effects on dendritic cells
黄体酮通过对树突状细胞的免疫抑制作用促进乳腺肿瘤发生
  • 批准号:
    10464253
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Influence of genetic variants on steroid hormone metabolism and progestin-related side effects in contraceptive implant users
遗传变异对避孕埋植剂使用者类固醇激素代谢和孕激素相关副作用的影响
  • 批准号:
    10356154
  • 财政年份:
    2021
  • 资助金额:
    $ 1.86万
  • 项目类别:
Project 01: Understanding Racial Disparity in Endometrial Cancer through Tumor Genomics
项目01:通过肿瘤基因组学了解子宫内膜癌的种族差异
  • 批准号:
    10265427
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
Project 01: Understanding Racial Disparity in Endometrial Cancer through Tumor Genomics
项目01:通过肿瘤基因组学了解子宫内膜癌的种族差异
  • 批准号:
    10488638
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
黄体酮受体 (PR) 信号串扰导致 ER 乳腺癌
  • 批准号:
    10593962
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
Restoring Progestin Sensitivity in Endometrial Cancer
恢复子宫内膜癌的孕激素敏感性
  • 批准号:
    10165666
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了